• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff.

作者信息

Stevens D R, Sawinski D, Blumberg E, Bloom R D, Trofe-Clark J

机构信息

Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Department of Medicine, Renal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Transpl Infect Dis. 2015 Aug;17(4):625-6. doi: 10.1111/tid.12396. Epub 2015 Jun 26.

DOI:10.1111/tid.12396
PMID:25919221
Abstract
摘要

相似文献

1
Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff.回应：低剂量缬更昔洛韦预防实体器官移植后巨细胞病毒感染：一项重要的权衡。
Transpl Infect Dis. 2015 Aug;17(4):625-6. doi: 10.1111/tid.12396. Epub 2015 Jun 26.
2
Lower-dose valganciclovir for the prevention of cytomegalovirus after solid organ transplantation: an important tradeoff.低剂量缬更昔洛韦用于实体器官移植后巨细胞病毒的预防：一项重要的权衡。
Transpl Infect Dis. 2015 Aug;17(4):623-4. doi: 10.1111/tid.12397. Epub 2015 Jun 15.
3
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.接受低剂量缬更昔洛韦预防治疗的巨细胞病毒供体阳性/受体阴性肾移植受者中突破性感染风险增加。
Transpl Infect Dis. 2015 Apr;17(2):163-73. doi: 10.1111/tid.12349. Epub 2015 Feb 6.
4
Efficacy and Safety of Low-Dose Versus Standard-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients.低剂量与标准剂量缬更昔洛韦预防中危肾移植受者巨细胞病毒病的疗效与安全性
Exp Clin Transplant. 2016 Oct;14(5):526-534. doi: 10.6002/ect.2015.0305. Epub 2016 Jun 15.
5
Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients.低剂量与高剂量缬更昔洛韦预防供体和受体均为巨细胞病毒阳性（D+/R+）肾移植受者巨细胞病毒病的疗效和安全性的多中心评估
Transpl Infect Dis. 2016 Dec;18(6):904-912. doi: 10.1111/tid.12609. Epub 2016 Nov 7.
6
Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients.低剂量与高剂量缬更昔洛韦预防高危肾移植受者巨细胞病毒病的评价。
Transplantation. 2015 Jul;99(7):1499-505. doi: 10.1097/TP.0000000000000570.
7
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients.缬更昔洛韦预防巨细胞病毒感染会损害肾移植受者的淋巴细胞增殖和活化。
Antivir Ther. 2011;16(8):1227-35. doi: 10.3851/IMP1879.
8
Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin.低剂量缬更昔洛韦预防用药对接受抗胸腺细胞球蛋白治疗的巨细胞病毒血清学阳性心脏移植受者有效且安全。
Transpl Infect Dis. 2018 Jun;20(3):e12868. doi: 10.1111/tid.12868. Epub 2018 Mar 31.
9
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.缬更昔洛韦与伐昔洛韦预防肾移植受者巨细胞病毒感染的随机试验
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):294-304. doi: 10.2215/CJN.07020714. Epub 2014 Nov 25.
10
The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation.缬更昔洛韦与口服更昔洛韦在预防实体器官移植术后儿童有症状巨细胞病毒感染方面的疗效和安全性。
Pediatr Transplant. 2010 Sep 1;14(6):753-60. doi: 10.1111/j.1399-3046.2010.01330.x. Epub 2010 May 3.